abstract |
A pharmaceutical composition, the composition comprising: (a) a GM-CSF neutralizing compound; and (b) a neutralizing compound of IL-17, in which the neutralizing compound of GM-CSF is an antibody or functional fragment thereof binding to GM-CSF, and in which the neutralizing compound of IL-17 is a antibody or functional fragment thereof binding to IL-17. |